|
1
|
Kokemueller H, Eckardt A, Brachvogel P and
Hausamen JE: Adenoid cystic carcinoma of the head and neck - a 20
years experience. Int J Oral Maxillofac Surg. 33:25–31. 2004.
View Article : Google Scholar
|
|
2
|
Gondivkar SM, Gadbail AR, Chole R and
Parikh RV: Adenoid cystic carcinoma: A rare clinical entity and
literature review. Oral Oncol. 47:231–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
van Weert S, Bloemena E, van der Waal I,
de Bree R, Rietveld DH, Kuik JD and Leemans CR: Adenoid cystic
carcinoma of the head and neck: A single-center analysis of 105
consecutive cases over a 30-year period. Oral Oncol. 49:824–829.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu J, Shao C, Tan ML, Mu D, Ferris RL and
Ha PK: Molecular biology of adenoid cystic carcinoma. Head Neck.
34:1665–1677. 2012. View Article : Google Scholar
|
|
5
|
Grimm M, Henopp T, Hoefert S, Schaefer F,
Kluba S, Krimmel M and Reinert S: Multiple osteolytic lesions of
intraosseous adenoid cystic carcinoma in the mandible mimicking
apical periodontitis. Int Endod J. 45:1156–1164. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wal JE, Becking AG, Snow GB and van der
Waal I: Distant metastases of adenoid cystic carcinoma of the
salivary glands and the value of diagnostic examinations during
follow-up. Head Neck. 24:779–783. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Y, Yu T, Fu X, Chen J, Liu Y, Li C,
Xia Y, Zhang Z and Li L: EGFR inhibition prevents in vitro tumor
growth of salivary adenoid cystic carcinoma. BMC Cell Biol.
14:132013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jaso J and Malhotra R: Adenoid cystic
carcinoma. Arch Pathol Lab Med. 135:511–515. 2011.PubMed/NCBI
|
|
9
|
Persson M, Andrén Y, Mark J, Horlings HM,
Persson F and Stenman G: Recurrent fusion of MYB and NFIB
transcription factor genes in carcinomas of the breast and head and
neck. Proc Natl Acad Sci USA. 106:18740–18744. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Brill LB II, Kanner WA, Fehr A, Andrén Y,
Moskaluk CA, Löning T, Stenman G and Frierson HF Jr: Analysis of
MYB expression and MYB-NFIB gene fusions in adenoid cystic
carcinoma and other salivary neoplasms. Mod Pathol. 24:1169–1176.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Persson M, Andrén Y, Moskaluk CA, Frierson
HF Jr, Cooke SL, Futreal PA, Kling T, Nelander S, Nordkvist A,
Persson F, et al: Clinically significant copy number alterations
and complex rearrangements of MYB and NFIB in head and neck adenoid
cystic carcinoma. Genes Chromosomes Cancer. 51:805–817. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mitani Y, Li J, Rao PH, Zhao YJ, Bell D,
Lippman SM, Weber RS, Caulin C and El-Naggar AK: Comprehensive
analysis of the MYB-NFIB gene fusion in salivary adenoid cystic
carcinoma: Incidence, variability, and clinicopathologic
significance. Clin Cancer Res. 16:4722–4731. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brayer KJ, Frerich CA, Kang H and Ness SA:
Recurrent fusions in MYB and MYBL1 define a common, transcription
factor-driven oncogenic pathway in salivary gland adenoid cystic
carcinoma. Cancer Discov. 6:176–187. 2016. View Article : Google Scholar :
|
|
14
|
West RB, Kong C, Clarke N, Gilks T,
Lipsick JS, Cao H, Kwok S, Montgomery KD, Varma S and Le QT: MYB
expression and translocation in adenoid cystic carcinomas and other
salivary gland tumors with clinicopathologic correlation. Am J Surg
Pathol. 35:92–99. 2011. View Article : Google Scholar :
|
|
15
|
Argyris PP, Wetzel SL, Greipp P, Wehrs RN,
Knutson DL, Kloft-Nelson SM, García JJ and Koutlas IG: Clinical
utility of myb rearrangement detection and p63/p40
immunophenotyping in the diagnosis of adenoid cystic carcinoma of
minor salivary glands: A pilot study. Oral Surg Oral Med Oral
Pathol Oral Radiol. 121:282–289. 2016. View Article : Google Scholar
|
|
16
|
Belloni E, Shing D, Tapinassi C, Viale A,
Mancuso P, Malazzi O, Gerbino E, Dall'Olio V, Egurbide I, Odero MD,
et al: In vivo expression of an aberrant MYB-GATA1 fusion induces
leukemia in the presence of GATA1 reduced levels. Leukemia.
25:733–736. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ramsay RG and Gonda TJ: MYB function in
normal and cancer cells. Nat Rev Cancer. 8:523–534. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Jin K, van Pelt GW, van Dam H, Yu X,
Mesker WE, Ten Dijke P, Zhou F and Zhang L: c-Myb enhances breast
cancer invasion and metastasis through the Wnt/β-catenin/Axin2
pathway. Cancer Res. 76:3364–3375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Costa AF, Altemani A, García-Inclán C,
Fresno F, Suárez C, Llorente JL and Hermsen M: Analysis of MYB
oncogene in transformed adenoid cystic carcinomas reveals distinct
pathways of tumor progression. Lab Invest. 94:692–702. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dong L, Wang YX, Li SL, Yu GY, Gan YH, Li
D and Wang CY: TGF-beta1 promotes migration and invasion of
salivary adenoid cystic carcinoma. J Dent Res. 90:804–809. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gibbons DL and Creighton CJ: Pan-cancer
survey of epithelial-mesenchymal transition markers across the
Cancer Genome Atlas. Dev Dyn. 247:555–564. 2018. View Article : Google Scholar
|
|
22
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang MH, Hsu DS, Wang HW, Wang HJ, Lan HY,
Yang WH, Huang CH, Kao SY, Tzeng CH, Tai SK, et al: Bmi1 is
essential in Twist1-induced epithelial-mesenchymal transition. Nat
Cell Biol. 12:982–992. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thiery JP, Acloque H, Huang RYJ and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yang WW, Yang LQ, Zhao F, Chen CW, Xu LH,
Fu J, Li SL and Ge XY: Epiregulin promotes lung metastasis of
salivary adenoid cystic carcinoma. Theranostics. 7:3700–3714. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Levene A: International Histological
Classification of Tumours No. 7 Histological Typing of Salivary
Gland Tumours. J Clin Pathol. 26:8951973. View Article : Google Scholar
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(- Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
28
|
Li SL: Establishment of a human cancer
cell line from adenoid cystic carcinoma of the minor salivary
gland. Zhonghua Kou Qiang Yi Xue Za Zhi. 25:29–31. 1990.In
Chinese.
|
|
29
|
Du ZH, Li SL, Ge XY, Yu GY and Ding C:
Comparison of the secretory related molecules expression in stem
cells from the pulp of human exfoliated deciduous teeth and dental
pulp stem cells. Zhonghua Kou Qiang Yi Xue Za Zhi. 53:741–747.
2018.In Chinese. PubMed/NCBI
|
|
30
|
Kilkenny C, Browne WJ, Cuthill IC, Emerson
M and Altman DG: Improving bioscience research reporting: The
ARRIVE guidelines for reporting animal research. Osteoarthritis
Cartilage. 20:256–260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hollands C: The Animals (scientific
procedures) Act 1986. Lancet. 2:32–33. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Grignaschi G, Redaelli V, Luzi F and
Fornasier M: The bodies in charge of animal welfare: What they do
and what they could do? Front Physiol. 9:3912018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ramos-García P, Gil-Montoya JA, Scully C,
Ayén A, González-Ruiz L, Navarro-Triviño FJ and González-Moles MA:
An update on the implications of cyclin D1 in oral carcinogenesis.
Oral Dis. 23:897–912. 2017. View Article : Google Scholar
|
|
34
|
Xiang W, Yang CY and Bai L: MCL-1
inhibition in cancer treatment. OncoTargets Ther. 11:7301–7314.
2018. View Article : Google Scholar
|
|
35
|
Quintana AM, Liu F, O'Rourke JP and Ness
SA: Identification and regulation of c-Myb target genes in MCF-7
cells. BMC Cancer. 11:302011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Huang H: Matrix metalloproteinase-9
(MMP-9) as a cancer biomarker and MMP-9 biosensors: Recent
advances. Sensors (Basel). 18:182018. View Article : Google Scholar
|
|
37
|
Srivastava SK, Bhardwaj A, Arora S, Singh
S, Azim S, Tyagi N, Carter JE, Wang B and Singh AP: MYB is a novel
regulator of pancreatic tumour growth and metastasis. Br J Cancer.
113:1694–1703. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Srivastava SK, Bhardwaj A, Singh S, Arora
S, McClellan S, Grizzle We, Reed E and Singh AP: Myb overexpression
overrides androgen depletion-induced cell cycle arrest and
apoptosis in prostate cancer cells, and confers aggressive
malignant traits: Potential role in castration resistance.
Carcinogenesis. 33:1149–1157. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Pattabiraman DR and Gonda TJ: Role and
potential for therapeutic targeting of MYB in leukemia. Leukemia.
27:269–277. 2013. View Article : Google Scholar
|
|
40
|
Cheasley D, Pereira L, Sampurno S, Sieber
O, Jorissen R, Xu H, Germann M, Yuqian Y, Ramsay RG and Malaterre
J: Defective Myb function ablates cyclin E1 expression and perturbs
intestinal carcinogenesis. Mol Cancer Res. 13:1185–1196. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ku DH, Wen SC, Engelhard A, Nicolaides NC,
Lipson KE, Marino TA and Calabretta B: c-myb transactivates cdc2
expression via Myb binding sites in the 5′-flanking region of the
human cdc2 gene. J Biol Chem. 268:2255–2259. 1993.PubMed/NCBI
|
|
42
|
Nakata Y, Shetzline S, Sakashita C, Kalota
A, Rallapalli R, Rudnick SI, Zhang Y, Emerson SG and Gewirtz AM:
c-Myb contributes to G2/M cell cycle transition in human
hematopoietic cells by direct regulation of cyclin B1 expression.
Mol Cell Biol. 27:2048–2058. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu F, Lei W, O'Rourke JP and Ness SA:
Oncogenic mutations cause dramatic, qualitative changes in the
transcriptional activity of c-Myb. Oncogene. 25:795–805. 2006.
View Article : Google Scholar
|
|
44
|
Gravina GL, Mancini A, Marampon F,
Colapietro A, Delle Monache S, Sferra R, Vitale F, Richardson PJ,
Patient L, Burbidge S, et al: The brain-penetrating CXCR4
antagonist, PRX177561, increases the antitumor effects of
bevacizumab and sunitinib in preclinical models of human
glioblastoma. J Hematol Oncol. 10:52017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Knopfová L, Beneš P, Pekarčíková L,
Hermanová M, Masařík M, Pernicová Z, Souček K and Smarda J: c-Myb
regulates matrix metalloproteinases 1/9, and cathepsin D:
Implications for matrix-dependent breast cancer cell invasion and
metastasis. Mol Cancer. 11:152012. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen RX, Xia YH, Xue TC and Ye SL:
Transcription factor c-Myb promotes the invasion of hepatocellular
carcinoma cells via increasing osteopontin expression. J Exp Clin
Cancer Res. 29:1722010. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Oka N, Soeda A, Inagaki A, Onodera M,
Maruyama H, Hara A, Kunisada T, Mori H and Iwama T: VEGF promotes
tumorigenesis and angiogenesis of human glioblastoma stem cells.
Biochem Biophys Res Commun. 360:553–559. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Sluiter N, de Cuba E, Kwakman R, Kazemier
G, Meijer G and Te Velde EA: Adhesion molecules in peritoneal
dissemination: Function, prognostic relevance and therapeutic
options. Clin Exp Metastasis. 33:401–416. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lauer-Fields JL, Whitehead JK, Li S,
Hammer RP, Brew K and Fields GB: Selective modulation of matrix
metalloproteinase 9 (MMP-9) functions via exosite inhibition. J
Biol Chem. 283:20087–20095. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sala A: c-MYB and TGFβ: EMT's dynamic duo
in breast cancer. Cell Cycle. 11:172012. View Article : Google Scholar
|
